Glucocorticoids influence memory processing in all stages, i.e., encoding, consolidation, and retrieval (de Quervain et al. 2009 ). The effects vary depending on the level of the hormone and on the emotionality of the memory. In particular, for the effects on encoding of new information (including subsequent consolidation), an inverted U-shaped function has been proposed, with moderate glucocorticoid concentrations enhancing these processes, but very low and very high concentrations exerting a diminishing effect (de Kloet et al. 1999; Newcomer et al. 1999; Roozendaal 2000; Abercrombie et al. 2003; Maheu et al. 2004) . Compared with encoding, the effects of glucocorticoids on memory retrieval have been less well-investigated. Most studies examined retrieval under moderately elevated glucocorticoid levels induced by either administering the major glucocorticoid, i.e., cortisol in humans and corticosterone in rats, or by stress. These studies consistently showed that moderately elevated glucocorticoid levels impair memory retrieval in both rats (de Quervain et al. 1998; Roozendaal et al. 2003 Roozendaal et al. , 2004 ) and humans (de Quervain et al. 2000 (de Quervain et al. , 2009 Domes et al. 2004 Domes et al. , 2005 Kuhlmann et al. 2005a,b; Buchanan et al. 2006; Buchanan and Tranel 2008) . Of note, in rats the retrieval impairment associated with elevated glucocorticoid levels could be abolished by administration of the glucocorticoid synthesis inhibitor metyrapone (de Quervain et al. 1998; Roozendaal et al. 2001) . Additionally, there is evidence that the glucocorticoid-induced retrieval impairment occurs specifically for emotionally arousing information (Kuhlmann et al. 2005a,b; de Quervain et al. 2007; Smeets et al. 2008; Tollenaar et al. 2009 ) or in emotionally arousing testing situations (Kuhlmann and Wolf 2006) .
While the impairing effect of glucocorticoids on retrieval is well documented, it is presently not clear whether this adverse effect can be prevented by blocking the occurrence of elevated cortisol levels in humans. Cortisol levels are naturally not only increased during stress, but due to the circadian rhythm and an additional response to morning awakening, cortisol is also distinctly increased to stress-like levels in the morning hours (Born et al. 1999; Wilhelm et al. 2007 ). Memory retrieval, indeed, seems to be less efficient in these morning hours compared with afternoon or evening hours, when cortisol is low (Tilley and Warren 1983; Het et al. 2005; Yang et al. 2007 ). Here, we took this morning rise in cortisol (combining circadian and awakening-related cortisol release) as a model to examine whether the impairing effect of elevated glucocorticoid levels on retrieval can be prevented by administration of metyrapone.
Sixteen healthy men (mean + SD: 22.3 + 3.89 yr of age) participated in the double-blind, within-subject crossover study. (For a detailed description of methods and additional results, please see Supplemental material.) The study was approved by the local ethics committee. After an adaptation night in the laboratory, each participant was tested in two conditions (metyrapone vs. placebo), separated by an interval of at least 12 d, with the order of conditions balanced across subjects. Each condition included a learning session and a retrieval session (Fig. 1A) . In the learning session (9:00 a.m.-11:00 a.m.), participants memorized emotional and neutral texts (Wagner et al. 2005) and pictures (Lang 1999) . Thereafter, as a measure of encoding level, immediate free recall was tested. In the retrieval session (7:30 a.m. -8:30 a.m.) 3d later, retrieval of the materials was assessed by a free recall and a recognition test. Retrieval testing took place following oral administration of either metyrapone (3 g, Novartis Pharma) or placebo at 4:00 a.m. In pilot experiments this timing, in combination with the 3-g dose of metyrapone, had effectively suppressed the morning rise in cortisol. The dose was the same used previously by Wagner et al. (2005) , and twofold higher than that used in the studies by Lupien et al. (Lupien et al. 2002a,b; Maheu et al. 2005) . Adrenocortical and autonomic responses to metyrapone were assessed by repeated measures of salivary cortisol and a-amylase levels, as well as heart rate.
Salivary cortisol at the time of retrieval testing (7:30 a.m. -8:30 a.m.) was strongly increased after placebo (0.51 + 0.14 mg/ dl), but suppressed to very low levels after metyrapone (0.086 + 0.007 mg/dl, P , 0.001; for effects of treatment; Fig. 1B ). In the learning session before treatment, as expected, immediate recall of texts and pictures did not differ between the metyrapone and placebo conditions (all P . 0.17), but generally participants recalled the emotional texts and pictures, as well as details of emotional pictures, better than the respective neutral materials (P , 0.001 for all effects of emotionality, see Table 1 for a summary of results from the learning session).
Contrary to our expectation, administration of metyrapone before the retrieval session, compared with placebo, distinctly impaired the free recall of all memories. Metyrapone significantly diminished recall of both emotional and neutral texts (percentage of recalled content words with reference to learning performance 67.53% + 3.9% vs. 85.39% + 2.5% after placebo; F (1,14) ¼ 13.02, P ¼ 0.003), with no differential influence on emotional vs. neutral texts (treatment Â emotionality P . 0.9; Fig. 2A ). This impairment was also reflected by the absolute number of content words recalled, which (collapsed across emotional and neutral texts) was 23.18 +1.95 after metyrapone and 28.56 + 1.96 after placebo (t (14) ¼ 2.34, P , 0.05). The absolute numbers of content words recalled was, as expected, higher for emotional (32.35 + 1.94) than neutral texts (19.35 + 1.94, P , 0.001). Recognition of texts assessed after free recall did not differ between the treatment conditions (P . 0.45, for all comparisons; see Supplemental material).
Similar to its effect on participants' memory for texts, metyrapone also impaired memory for pictures, an effect which was most pronounced for recall of the emotional items and of picture details. The percentage (with reference to learning performance) of recalled emotional pictures was after metyrapone (60.43 + 6.11%) and after placebo (76.48 + 3.49%; t (14) ¼ 2.81, P , 0.01). For the neutral pictures, a difference in the same direction failed to reach significance (63.83 + 6.86 vs. 69.19 + 7.77%, P . 0.61; P ¼ 0.14 for the respective treatment Â emotionality interaction). Recall of picture details was also markedly impaired after metyrapone, especially for emotional pictures (F (1,14) ¼ 5.25, P ¼ 0.038; treatment Â emotionality, F (1,14) ¼ 4.05, P ¼ 0.06 treatment main effect). Subjects after metyrapone recalled only 55.31 + 5.04% of the details from emotional pictures encoded during learning, whereas after placebo, 74.75 + 3.82% of the details were recalled (t (14) ¼ 4.50, P , 0.001). For the details from neutral pictures this difference was not significant (60.02 + 5.16 vs. 63.88 + 7.07%, P . 0.65). Recognition of pictures assessed after free recall (including measures of familiarity and recollection) did not differ between the treatment conditions (P . 0.19, for all comparisons; Fig. 2C ).
The impairing effect of metyrapone on memory retrieval cannot be explained by nonspecific effects on sleep (measured Figure 1. (A) Experimental procedure. At Learning, participants learned and immediately recalled texts and pictures of an emotional and neutral nature. Three d later, retrieval of the materials (Free recall followed by Recognition tests) was tested between 7:30 a.m. and 8:30 a.m., i.e., the time of the cortisol morning rise. Retrieval was tested after administration of either metyrapone (3 g) or placebo at 4:00 a.m. Subjects spent the night before retrieval testing in the sleep laboratory. (B) Mean + SEM salivary cortisol concentration at retrieval. Horizontal bar indicates time of retrieval testing. Metyrapone ( †) completely suppressed the morning cortisol rise apparent in the placebo condition (A, P , 0.001, for treatment Â interaction). (C ) Mean + SEM heart rate: Metyrapone induced a transient rise in heart rate (P , 0.01, for comparison at 5:00 a.m.), but during the time of retrieval testing, heart rate was comparable between the treatment conditions. by polysomnography), arousal, mood, and attention. Signs of a lightening of sleep after metyrapone, specifically a suppression of REM sleep (averaging 29.1 min, P , 0.01), were restricted to the 2.5-h interval after substance administration, whereas sleep before (i.e., 11:00 p.m.-4 a.m.) was well comparable between the conditions. Also, the reported sleep quality for the total night was not different between conditions (P . 0.30). Metyrapone also produced a temporary increase in heart rate between 4:00 a.m. and 7:00 a.m. (62.79 + 2.56 vs. 57.45 + 1.80 b/min following placebo, P , 0.01, Fig. 1C ) but, during the time of retrieval testing, heart rate as well as salivary a-amylase levels were closely comparable between conditions (heart rate: all P . 0.14, Fig. 1C ; average salivary a-amylase: metyrapone: 89.80 + 24.78 U/mL, placebo: 65.23 + 15.40 U/mL; P . 0.24). Changes in self-reported mood (assessed by the PANAS) were likewise negligible, with only a marginal increase in negative affect after metyrapone vs. placebo (13.33 + 0.92 vs. 12.27 + 0.80, P ¼ 0.084, P . 0.17 for all other measures). It could be also argued that the morning rise in cortisol affects memory function nonspecifically by enhancing attentional capacities. Attention was found to be impaired in Addison patients with chronically low cortisol levels (Klement et al. 2009 ) and in healthy humans after blocking mineralocorticoid receptors (MRs) with spironolactone (Otte et al. 2007) . For this reason, as a control, we assessed attention by a letter cancellation test, which indeed revealed a distinctly diminished performance after metyrapone (correctly cancelled letters minus false alarms 418.53 + 23.00 vs. 524.30 + 23.90 after placebo; P , 0.001). However, additional statistical analyses showed virtually no correlation between the metyrapone-induced changes in attention and memory performance (r ¼ 0.03; P . 0.90). Also, a comparison of (mediansplit-half) groups of subjects with strong vs. no or weak changes in attention performance after metyrapone did not reveal any significant association with retrieval performance (all P . 0.20), overall excluding that impaired retrieval after metyrapone is sufficiently explained by a decrement of attention. Finally, it is also unlikely that the observed retrieval impairment is mediated by pituitary ACTH or/and hypothalamic CRH, whose release is enhanced after metyrapone-induced suppression of cortisol. Generally, these two hormones appear to exert only minor effects on retrieval functions and, if at all, these are toward enhancing retrieval efficiency (Born et al. 1986; Kumar and Karanth 1995; Ohmura et al. 2008) .
Our study is the first to specifically examine the impact of suppressed cortisol levels on retrieval in humans. The central finding is that the suppression of the morning cortisol rise impaired free recall of emotional and neutral texts and pictures while leaving recognition unaffected. An impairing effect of metyrapone on retrieval has previously been suggested by several human studies (Lupien et al. 2002a,b; Maheu et al. 2005) . However, the design of those studies did not allow to dissociate effects on retrieval from effects on encoding or consolidation, because metyrapone was effective during both learning and recall of word lists or a short story. In the present study, metyrapone was administered specifically prior to retrieval testing, eliminating any possible effects on encoding and consolidation, because learning took place 3 d before and was closely comparable in both treatment conditions. The finding of impaired retrieval after suppression of cortisol contrasts with the well-documented impairment of retrieval in conditions of elevated glucocorticoid levels (de Quervain et al. 2009; Schwabe et al. 2009 ). Interestingly, in rats the administration of metyrapone prior to retrieval did not only distinctly decrease circulating corticosterone levels, but in parallel, blocked the glucocorticoid-induced retrieval impairment (de Quervain et al. 1998) . At first glance, this finding is at odds with the present study, where metyrapone-suppressed cortisol levels were associated with impaired rather than improved retrieval performance. However, the dose of metyrapone administered in the rat study was such that circulating corticosterone was at an intermediate level, whereas in the present study metyrapone almost completely suppressed cortisol levels, leading to levels close to and even below the assay Text recall at learning and retrieval (absolute number of content words, for learning additionally percent values with reference to total number of content words is given). Retention refers to the change from learning to retrieval. Retention of neutral and emotional texts is given in percent values in relation to learning performance. Metyrapone significantly decreased retention of both emotional and neutral texts (P ¼ 0.003, for main effect of treatment). Right two columns indicate results from pairwise statistical comparisons. sensitivity during the period of retrieval testing. Taken together, these findings indeed support the previously proposed notion (Lupien and Lepage 2001; Domes et al. 2005 ) that the influence of circulating glucocorticoid levels follows an inverted-U shaped function, where retrieval is not only impaired under high cortisol levels, but also under extremely low levels (as reached in the present experiments). This inverted U-shaped relationship may basically originate from differential contributions of MRs and glucocorticoid receptors (GRs) to retrieval processes. MRs bind cortisol with distinctly higher affinity than GRs, resulting in abundant MR occupation even during the circadian nadir of cortisol. In contrast, GRs become increasingly activated only after MRs are saturated to a great extent (Reul and de Kloet 1985; Joels and de Kloet 1994; de Kloet et al. 2005) . Considering the minimal cortisol levels after metyrapone in our subjects, the retrieval impairment is likely to reflect a consequence of insufficient MR occupation after metyrapone. Unlike GRs, which are widely expressed in the brain, MRs are predominantly expressed in hippocampal and amygdalar regions, where they can mediate actions on neuronal activity virtually opposite those of GRs (Reul and de Kloet 1985; Korz and Frey 2003; de Kloet et al. 2005 ). Thus, impaired retrieval cannot only be a consequence of insufficient activation of hippocampal MRs, but likewise a consequence of predominant GR activation induced, for example, by administration of glucocorticoids. Of note, the circadian rise in glucocorticoid level, used here as a condition of elevated cortisol, is accompanied by an enhancement (by 65%) in numbers of MRs, a relation that is not seen during stress-induced elevations of glucocorticoid levels (Reul et al. 1987) . Blocking the morning rise in cortisol by metyrapone might therefore be particularly effective in increasing the proportion of unoccupied MRs and, consequently, in demonstrating the dependence of retrieval on MR occupation.
Although GR-related contributions to the retrieval deficit after metyrapone (arising from insufficient occupation of GRs) cannot be excluded (Oitzl and de Kloet 1992) , a primary role for MRs in mediating retrieval deficits after metyrapone would also be consistent with the failure of metyrapone to affect recognition. Previous studies indicated that recognition memory is also spared from the impairing effects of elevated cortisol levels (de Quervain et al. 2000 Buchanan et al. 2006) . Free recall and recognition involve different brain systems. Whereas free recall critically relies on the prefrontal cortex and hippocampus, and therefore is probably most sensitive to disturbing influences mediated via MRs located at high density in hippocampal networks, hippocampal contributions to recognition performance are less essential (Mayes et al. 2002; Holdstock et al. 2005) . Along this line of reasoning, the overall stronger retrieval impairment for emotional rather than neutral pictures could be likewise linked to the particularly high density of MRs in the amygdala, a region critically involved in the retrieval of emotional memories (Buchanan 2007) .
To summarize, the present study has uniquely shown that metyrapone administration and subsequent suppression of the morning cortisol rise impairs free recall. Combined with previous studies, which indicate an impairing effect of elevated cortisol levels on retrieval, our findings are in line with the view that the dependence of memory retrieval on circulating cortisol follows an inverted U-shaped function, and suggest that the retrieval impairment occurring at minimum cortisol concentrations (after metyrapone) results from an insufficient occupation of hippocampal and amygdalar MRs.
